BRIDGET FRAZER: Open Payments
NPI 1619079167 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$589 in 23 payments from 9 companies in 2025. Trend: 2023 $307 · 2024 $227 · 2025 $589
Food & beverage: $589
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 4 | $192 |
| ABBVIE INC. | 8 | $151 |
| TerSera Therapeutics LLC | 2 | $63 |
| DePuy Synthes Sales Inc. | 2 | $52 |
| Merz Pharmaceuticals, LLC | 2 | $49 |
| BIOTRONIK NRO, Inc. | 2 | $34 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Forte Bio-Pharma LLC | 1 | $14 |
| MicroTransponder, Inc. | 1 | $14 |
Products named: Intracept, BOTOX, Prialt, MONOVISC, Xeomin, Prospera, General - Pain Management, Belbuca.
Industry payments across NE — which companies pay providers there.
